Pular para o conteúdo
Merck
  • Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.

Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.

Oncogene (2015-11-10)
M E Buczek, A K Miles, W Green, C Johnson, D J Boocock, A G Pockley, R C Rees, G Hulman, G van Schalkwyk, R Parkinson, J Hulman, D G Powe, T Regad
RESUMO

Epithelial-mesenchymal transition (EMT) is a key event that is involved in the invasion and dissemination of cancer cells. Although typically considered as having tumour-suppressive properties, transforming growth factor (TGF)-β signalling is altered during cancer and has been associated with the invasion of cancer cells and metastasis. In this study, we report a previously unknown role for the cytoplasmic promyelocytic leukaemia (cPML) tumour suppressor in TGF-β signalling-induced regulation of prostate cancer-associated EMT and invasion. We demonstrate that cPML promotes a mesenchymal phenotype and increases the invasiveness of prostate cancer cells. This event is associated with activation of TGF-β canonical signalling pathway through the induction of Sma and Mad related family 2 and 3 (SMAD2 and SMAD3) phosphorylation. Furthermore, the cytoplasmic localization of promyelocytic leukaemia (PML) is mediated by its nuclear export in a chromosomal maintenance 1 (CRM1)-dependent manner. This was clinically tested in prostate cancer tissue and shown that cytoplasmic PML and CRM1 co-expression correlates with reduced disease-specific survival. In summary, we provide evidence of dysfunctional TGF-β signalling occurring at an early stage in prostate cancer. We show that this disease pathway is mediated by cPML and CRM1 and results in a more aggressive cancer cell phenotype. We propose that the targeting of this pathway could be therapeutically exploited for clinical benefit.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Antiβ-actina monoclonal, clone AC-15, ascites fluid
Sigma-Aldrich
Anti-phospho-SMAD3 (pSer425) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-Smad2 (pSer250) antibody produced in rabbit, affinity isolated antibody